Anna Marina Liberati

机构：Azienda Ospedaliera S.Maria · ORCID：0000-0002-3686-3188

发表论文 451 篇 · 总被引 14482 次 · h-index 51

代表论文

• Omission of Radiotherapy in Primary Mediastinal B-Cell Lymphoma: IELSG37 Trial Results (2024 · Journal of Clinical Oncology · 被引 30)
• IELSG30 phase 2 trial: intravenous and intrathecal CNS prophylaxis in primary testicular diffuse large B-cell lymphoma (2024 · Blood Advances · 被引 29)
• Real-World Outcome of Treatment with Single-Agent Ibrutinib in Italian Patients with Chronic Lymphocytic Leukemia: Final Results of the EVIdeNCE Study (2024 · Cancers · 被引 20)
• Bortezomib, melphalan, and prednisone with or without daratumumab in transplant-ineligible patients with newly diagnosed multiple myeloma (ALCYONE): final analysis of an open-label, randomised, multicentre, phase 3 trial (2025 · The Lancet Oncology · 被引 19)
• Dosing and clinical outcomes of ruxolitinib in patients with myelofibrosis in a real‐world setting: Interim results of the Italian observational study (ROMEI) (2025 · Cancer · 被引 14)
• Additional copies of 1q negatively impact the outcome of multiple myeloma patients and induce transcriptomic deregulation in malignant plasma cells (2024 · Blood Cancer Journal · 被引 13)